WHEELER BIO

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Jun 2025 filing date already counts against anyone who files later.

Record

Serial number

99256856

Mark type

Stylized text

Filed

27 Jun 2025

Published for opposition

10 Mar 2026

Attorney of record

Ava R. Shelby

Goods and services

• Class 035 — Advertising and business services: Business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; Business management services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control services, namely, computerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit for business purposes; electronic customer ordering services for pharmaceuticals, pharmaceutical products, medical products and equipment, laboratory supplies and equipment
• Class 039 — Transportation and storage services: Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceuticals, biopharmaceuticals, pharmaceutical products, health care products and medical products; supply chain, logistics and reverse logistics services, namely, storage, transportation and delivery of pharmaceuticals and pharmaceutical products for others by air, rail, ship, or truck; packaging of clinical, pharmaceutical and health care products to the order and specification of others
• Class 040 — Treatment of materials: Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for others, namely, manufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development
• Class 042 — Scientific and technological services: Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticals, biopharmaceuticals, pharmaceutical preparations, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for others, namely, mammalian cell line development and therapeutic antibody development; development and analysis services relating to the use of mammalian cell cultures in the field of biotechnology; providing medical and scientific technology research information in the field of pharmaceuticals and biopharmaceuticals, including discovery, preclinical, and clinical drug research and development; toxicological safety testing services for pharmaceuticals and biopharmaceuticals; pharmaceutical contract development in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development; laboratory testing services in clinical research and clinical trials of innovator medicines in the pharmaceutical and biotechnology fields; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical and biopharmaceutical drug development; analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of pharmaceutical and biopharmaceutical drug evaluation and development

Owner

• Wheeler Bio, Inc., Oklahoma City, OK, US
• Wheeler Bio, Inc., Oklahoma City, OK, US

Prosecution history

• 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Mar 2026 — PUBLISHED FOR OPPOSITION
• 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 11 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 18 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Nov 2025 — NON-FINAL ACTION E-MAILED
• 18 Nov 2025 — NON-FINAL ACTION WRITTEN
• 17 Nov 2025 — ASSIGNED TO EXAMINER
• 27 Jun 2025 — APPLICATION FILING RECEIPT MAILED
• 27 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 27 Jun 2025 — NEW APPLICATION ENTERED